| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |